CD274 and neoplasm: Moreover, we further demonstrated that this strategy could induce specific antitumor immune response in B6 mice bearing B16F10 tumor, significantly increasing anti-PD-L1 therapy response, making our Ag2S QDs platform promise in cancer radioimmunotherapy.